SMMT

Summit Therapeutics Inc.NASDAQHealthcare

$19.38+2.43%ClosedMarket Cap: $14.43B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-16	Jefferies	—	Hold	—
2026-02-24	HC Wainwright & Co.	—	Buy	—
2026-01-30	Citizens	—	Market Outperform	—
2025-12-17	Barclays	—	Equal Weight	—
2025-10-22	Guggenheim	—	Buy	—
2025-10-21	HC Wainwright & Co.	—	Buy	—
2025-10-21	Barclays	—	Underweight	—
2025-10-20	JMP Securities	—	Market Outperform	—
2025-10-20	Citigroup	—	Buy	—
2025-09-16	HC Wainwright & Co.	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-1.16	$108.3M	5
Sun Dec 31	$-0.25	$936.4M	6
Mon Dec 31	$0.65	$2.51B	4
Tue Dec 31	$1.89	$4.44B	2